NICOLAS M. BARTHELEMY - Corporate Board Profile

REPLIGEN CORP

Filing Date	Source Excerpt
2015-04-17	Nicolas M. Barthelemy has served as Director of Repligen since June 2014. Mr. Barthelemy brings over 20 years of industry experience to the director role, and he currently serves as President and CEO of bioTheranostics, Inc. ... Mr. Barthelemy currently serves on the boards of directors of IROA Technologies and Essen Bioscience. ... Mr. Barthelemy's qualifications to sit on the Company's Board of Directors include his extensive experience in the bioprocessing field, including large scale biologics manufacturing and commercialization of consumables used in bioprocessing. ... Compensation Committee, of which Dr. Cooper, Mr. Griffith and Mr. Barthelemy (who replaced Dr. Goldberg on the Compensation Committee in December 2014) are currently members ... Director Compensation Table for the Fiscal Year Ended December 31, 2014 ... Nicolas M. Barthelemy 19,444 Fees Earned or Paid in Cash ($) 256,416 Option Awards ($) Total 275,860
2016-04-11	Nicolas M. Barthelemy has served as Director of Repligen since June 2014. Mr. Barthelemy brings over 20 years of industry experience to the director role, and he currently serves as President and CEO of bioTheranostics, Inc. ... Mr. Barthelemy currently serves on the boards of directors of bioTheranostics and Essen Bioscience. ... Mr. Barthelemy received an M.S. in Chemical Engineering from the University of California, Berkeley, and an engineering degree from Ecole Supérieure de Physique et Chimie Industrielles, Paris. ... Mr. Barthelemy's qualifications to sit on the Company's Board of Directors include his extensive experience in the bioprocessing field, including large scale biologics manufacturing and commercialization of consumables used in bioprocessing. ... The Compensation Committee, of which Dr. Cooper, Mr. Barthelemy and Mr. Muir (effective as of October 2015) are currently members ... The Nominating and Corporate Governance Committee of the Board of Directors consists currently of Ms. Dawes, Chairperson, Mr. Barthelemy and Mr. Ryan. ... Director Compensation Table for the Fiscal Year Ended December 31, 2015 ... Nicolas M. Barthelemy Fees Earned or Paid in Cash($) 53,472, Stock Awards($) 41,973, Option Awards($) 44,807, Total($) 140,252.
2017-04-21	Nicolas M. Barthelemy has served as Director of Repligen since June 2014. Mr. Barthelemy brings over 25 years of industry experience to the director role. ... Mr. Barthelemy currently serves on the board of directors of Fluidigm. ... Mr. Barthelemy's qualifications to sit on the Company's Board of Directors include his extensive experience in the bioprocessing field, including large scale biologics manufacturing and commercialization of consumables used in bioprocessing. ... Compensation Committee, of which Dr. Cooper, Mr. Barthelemy and Mr. Muir are currently members ... The Nominating and Corporate Governance Committee of the Board of Directors consists of Ms. Dawes, Chairperson, Mr. Barthelemy and Mr. Ryan. ... Director Compensation Table for the Fiscal Year Ended December 31, 2016 ... Nicolas M. Barthelemy 55,000 46,050 46,476 147,526
2018-04-20	Nicolas M. Barthelemy has served as Director of Repligen since June 2014. Mr. Barthelemy brings over 20 years of industry experience to the director role. ... Mr. Barthelemy currently serves on the board of directors of Fluidigm. ... Mr. Barthelemy received an M.S. in Chemical Engineering from the University of California, Berkeley, and an engineering degree from Ecole Supérieure de Physique et Chimie Industrielles, Paris. ... Mr. Barthelemy's qualifications to sit on the Company's Board of Directors include his extensive experience in the bioprocessing field, including large scale biologics manufacturing and commercialization of consumables used in bioprocessing.
2019-04-18	Nicolas M. Barthelemy has served as a director of Repligen since June 2014. ... Mr. Barthelemy currently serves on the board of directors of Fluidigm, 908 Devices and Biocare Medical. ... Mr. Barthelemy is a member of the Compensation Committee and the Nominating and Corporate Governance Committee. ... Director Compensation Table for the Fiscal Year Ended December 31, 2018: Nicolas M. Barthelemy Total Compensation: $190,370.
2020-04-28	Nicolas M. Barthelemy has served as a director of Repligen since June 2014. Mr. Barthelemy brings over 25 years of industry experience to the director role. Mr. Barthelemy also serves on the board of directors of two publicly traded companies; Fluidigm Corporation and Twist Bioscience.
2021-04-21	Nicolas M. Barthelemy has served as a director of Repligen since June 2014. Mr. Barthelemy served as President and CEO of bioTheranostics. He also serves on the board of directors of three publicly traded companies. Mr. Barthelemy serves as Chairperson of the Compensation Committee.
2022-04-11	Nicolas M. Barthelemy has served as a director of Repligen since June 2014. ... Mr. Barthelemy also serves on the board of directors of three publicly traded companies: Fluidigm Corporation, Twist Bioscience and 908 Devices Inc., and three privately held companies; Biocare Medical LLC, NanoCellect Biomedical, and Slingshot Biosciences. ... The Compensation Committee, of which Mr. Barthelemy, Mr. Muir and Dr. Mhatre are currently members, is responsible for: ... Mr. Barthelemy serves as the Chairperson of the Compensation Committee. ... Director Compensation Table for the Fiscal Year Ended December 31, 2021 shows total compensation $235,051.
2023-04-11	Nicolas M. Barthelemy Former President and Chief Executive Officer, bioTheranostics 57 2014 ✓ - CHAIR • 85,000 84,997 85,000 254,997
2024-04-01	Nicolas M. Barthelemy has served as a director of Repligen since June 2014. Mr. Barthelemy brings over 30 years of industry experience to the director role.
2025-04-04	Mr. Barthelemy received a M.S. in Chemical Engineering from the University of California, Berkeley, and an engineering degree from Ecole Supérieure de Physique et Chimie Industrielles, Paris.